ADVISORY BOARD AGREEMENTAdvisory Board Agreement • February 17th, 2011 • Medgenics, Inc. • Biological products, (no disgnostic substances) • New York
This AGREEMENT (this “Agreement”), dated as of December 10, 2010, is made by and between Medgenics, Inc., located at 8000 Towers Crescent Drive, Suite 1300, Vienna, VA, 22182 USA (the “Company”); and R. Dean Hautamaki, M.D., FCCP of Sarasota, Florida (the “Advisor”).
CONSULTING SERVICES AGREEMENTConsulting Services Agreement • February 17th, 2011 • Medgenics, Inc. • Biological products, (no disgnostic substances) • California
This Consulting Agreement (“Agreement”) is made as of October 18, 2010 (“Effective Date”) by and between Medgenics, Inc., a Delaware corporation (the “Company”), and Eugene A. Bauer.
LICENSE AGREEMENT University of Michigan File 1184License Agreement • February 17th, 2011 • Medgenics, Inc. • Biological products, (no disgnostic substances) • Michigan
This Agreement is effective as of January 31, 2011 (the “Effective Date”), between Medgenics, Inc. (including AFFILIATES collectively “LICENSEE”) having the address in Article 13 below, and the Regents of the University of Michigan, a constitutional corporation of the state of Michigan (“MICHIGAN”). This document executed February 15, 2011 replaces the agreement executed February 10 which was executed in error. LICENSEE and MICHIGAN agree as follows:
